Microfluidics for cell-based assays

被引:29
作者
Pihl, Johan [1 ]
Sinclair, Jon [2 ]
Karlsson, Mattias [1 ]
Orwar, Owe [2 ]
机构
[1] Cellectricon AB, SE-41250 Gothenburg, Sweden
[2] Chalmers Univ Technol, Dept Chem & Biosci, SE-41296 Gothenburg, Sweden
关键词
D O I
10.1016/S1369-7021(05)71224-4
中图分类号
T [工业技术];
学科分类号
08 ;
摘要
There has been enormous development in the field of microfluidic systems over the past decade(1-3). It has grown from a specialized area of research into a field engaging hundreds of research groups and a growing number of companies. The development of microfluidic systems was made possible by fabrication technologies developed in the microelectronics industry. This began in the late 1970s, when Terry et al.(4,5) demonstrated a gas chromatography system fabricated on a Si wafer, but received little attention until 1990, when Manz et al.(6) published the now classic paper on miniaturized total analysis systems (mu TAS). This resulted in a tremendous increase in the research of chip-based microfluidic systems, much like the revolution in the electronic industry after the invention of the transistor and the integrated circuit.
引用
收藏
页码:46 / 51
页数:6
相关论文
共 74 条
[41]  
McDonald JC, 2000, ELECTROPHORESIS, V21, P27, DOI 10.1002/(SICI)1522-2683(20000101)21:1<27::AID-ELPS27>3.0.CO
[42]  
2-C
[43]   Involvement of chemokine receptors in breast cancer metastasis [J].
Müller, A ;
Homey, B ;
Soto, H ;
Ge, NF ;
Catron, D ;
Buchanan, ME ;
McClanahan, T ;
Murphy, E ;
Yuan, W ;
Wagner, SN ;
Barrera, JL ;
Mohar, A ;
Verástegui, E ;
Zlotnik, A .
NATURE, 2001, 410 (6824) :50-56
[44]  
NELSON RD, 1975, J IMMUNOL, V115, P1650
[45]   Screening lead compounds for QT interval prolongation [J].
Netzer, R ;
Ebneth, A ;
Bischoff, U ;
Pongs, O .
DRUG DISCOVERY TODAY, 2001, 6 (02) :78-84
[46]   A microfluidics approach to the problem of creating separate solution environments accessible from macroscopic volumes [J].
Olofsson, J ;
Pihl, J ;
Sinclair, J ;
Sahlin, E ;
Karisson, M ;
Orwar, O .
ANALYTICAL CHEMISTRY, 2004, 76 (17) :4968-4976
[47]   Blocking characteristics of hKv1.5 and hKv4.3/hKChIP2.2 after administration of the novel antiarrhythmic compound AZD7009 [J].
Persson, F ;
Carlsson, L ;
Duke, G ;
Jacobson, I .
JOURNAL OF CARDIOVASCULAR PHARMACOLOGY, 2005, 46 (01) :7-17
[48]   Blocking characteristics of hERG, hNav1.5, and hKvLQT1/hminK after administration of the novel anti-arrhythmic compound AZD7009 [J].
Persson, F ;
Carlsson, L ;
Duker, G ;
Jacobson, I .
JOURNAL OF CARDIOVASCULAR ELECTROPHYSIOLOGY, 2005, 16 (03) :329-341
[49]   Localized chemical release from an artificial synapse chip [J].
Peterman, MC ;
Noolandi, J ;
Blumenkranz, MS ;
Fishman, HA .
PROCEEDINGS OF THE NATIONAL ACADEMY OF SCIENCES OF THE UNITED STATES OF AMERICA, 2004, 101 (27) :9951-9954
[50]   Microfluidic gradient-generating device for pharmacological profiling [J].
Pihl, J ;
Sinclair, J ;
Sahlin, E ;
Karlsson, M ;
Petterson, F ;
Olofsson, J ;
Orwar, O .
ANALYTICAL CHEMISTRY, 2005, 77 (13) :3897-3903